Z. Y. Lin

L. Y. Wang, J. Tsai, W. Chang, 2001, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.

L. Y. Wang, J. Tsai, W. Chang, 2001, The Journal of infection.

The prevalence of TT virus and GB virus C/hepatitis G virus infection in individuals with raised liver enzymes but without HBV or HCV infection in Taiwan

L. Y. Wang, J. Tsai, W. Chang, 2002, Epidemiology and Infection.

Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.

L. Y. Wang, W. Chang, W. Chang, 1999, Journal of clinical pathology.

Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B.

J. Tsai, J. Tsai, J. Jeng, 1994, Scandinavian journal of gastroenterology.

Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study.

J. Tsai, M. Ho, J. Tsai, 2008, Liver.

Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.

J. Tsai, M. Ho, J. Tsai, 1995, British Journal of Cancer.

Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.

J. Tsai, M. Ho, J. Tsai, 1997, British Journal of Cancer.

Incidence and associated factors of neutralizing anti-interferon antibodies among chronic hepatitis C patients treated with interferon in Taiwan.

L. Y. Wang, J. Tsai, W. Chang, 2000, Scandinavian journal of gastroenterology.

The genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection in southern Taiwan.

L. Y. Wang, W. Chang, M. Hsieh, 1996, The Kaohsiung journal of medical sciences.

Treatment of chronic hepatitis C with interferon-alpha: a preliminary report.

L. Y. Wang, W. Chang, M. Hsieh, 1996, The Kaohsiung journal of medical sciences.

Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection.

H. Margolis, J. Tsai, M. Ho, 1995, Clinical immunology and immunopathology.

Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis.

J. Tsai, M. Ho, W. Chang, 1996, Journal of hepatology.

Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.

J. Tsai, M. Ho, J. Tsai, 1996, British Journal of Cancer.

Clinical utility of color Doppler sonography in the differentiation of hepatocellular carcinoma from metastases and hemangioma

L. Y. Wang, J. Tsai, W. Chang, 1997, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Antibodies to hepatitis E and A viruses among patients with non-alcoholic chronic liver disease in Taiwan.

J. Tsai, J. Tsai, J. Jeng, 1994, Scandinavian Journal of Gastroenterology.

Immunoglobulin- and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis B virus infection.

H. Margolis, J. Tsai, M. Ho, 1998, Clinical immunology and immunopathology.

Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.

J. Tsai, M. Ho, J. Tsai, 1994, British Journal of Cancer.

Amphotericin B up‐regulates angiogenic genes in hepatocellular carcinoma cell lines

Z. Y. Lin, W. Chuang, Y. Chuang, 2009, European journal of clinical investigation.